metoclopramide has been researched along with Multiple System Atrophy Syndrome in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magnifico, F | 1 |
| Pierangeli, G | 1 |
| Barletta, G | 1 |
| Candela, C | 1 |
| Bonavina, G | 1 |
| Contin, M | 1 |
| Cortelli, P | 1 |
1 trial available for metoclopramide and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure.
Topics: Aged; Autonomic Nervous System Diseases; Dopamine Antagonists; Female; Heart Rate; Hemodynamics; Hum | 2001 |